WHO endorses MenAfriVac in battle against Meningitis

By Post Nigeria January 10, 2015 13:29

WHO endorses MenAfriVac in battle against Meningitis

The World Health Organization, WHO, has approved an effective and affordable vaccine called ‘MenAfriVac’ to fight Meningitis in Africa.

The UN health agency in a statement stressed that routine immunization on infants in the meningitis hotspots across Sub-Saharan Africa will commence to reduce fatalities associated with the disease.

WHO Director of the Department of Immunization, Vaccines and Biologicals Jean Marie Okwo-Bele, said “The introduction of meningitis vaccines has dealt the epidemic a fatal blow. Nonetheless, there is need for political commitment in meningitis belt countries in Africa to contain the disease,”

The Director of MVP Marie-Pierre Preziosi, made a remark during clinical trials in several African countries, with MenAfriVac saying, “Health officials will be able to ensure that population wide protection is sustained by routinely immunizing infants,”

The Director of Vaccine Access and Delivery at PATH, Kathy Neuzil, confirms that the new meningitis vaccine meets the international standards on quality, safety and efficacy.

His words “With MenAfriVac, we have created a revolutionary new model for vaccine development and now we stand on the brink of protecting an entire generation from a devastating disease,”

WHO has partnered with global health non-profit PATH and Serum Institute of India Limited, SIIL, to form the Meningitis Vaccine Project, MVP, that announced the introduction of MenAfriVac.